Brief: Infant Bacterial Therapeutics appoints Daniel Mackey new CFO
Oct 12 (Reuters) - Infant Bacterial Therapeutics AB
IBTb.ST :
* Names Daniel Mackey as Chief Financial Officer from Jan.
2017
* Mackey replaces Michael Owens in this role
Source text for Eikon: ID:nWkrjl0612
Further company coverage: IBTb.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Infant Bacterial Therapeutics AB
See all newsBrief: Infant Bacterial Therapeutics Gets FDA Request For Type B Pre-BLA Meeting
Brief: Infant Bacterial Therapeutics Q2 Operating Loss Widens To SEK 30.1 Mln
Brief: Infant Bacterial Therapeutics CFO Leaves The Company
Brief: Infant Bacterial Announces Phase III IBP-9414 Study Results
Brief: Infant Bacterial Therapeutics Q4 Operating Loss SEK 20.5 Mln